Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)

Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)

Introduction Anthracyclines are included in chemotherapy regimens to treat several different types of cancer and are extremely effective. However, it is recognised that a significant side effect is cardiotoxicity; anthracyclines can cause irreversible damage to cardiac cells and ultimately impaired...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard Graham, Chris Plummer, Michael Stewart, David Austin, Adetayo S Kasim, Nasima Akhter, Helen C Hancock, Rebecca H Maier, Mark Verrill, Emmanuel Ogundimu, Jamie Maddox, Janine Graham, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Lisa Chang
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/12/e066252.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/12/12/e066252.full

Similar Items